Home > Cashflow Statement > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
Cashflow Statement

KILITCH DRUGS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results

KILITCH DRUGS (INDIA) Last 5 Year Cashflow Statement History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Profit Before Tax₹19 Cr₹12 Cr₹9.61 Cr₹5.12 Cr₹1.61 Cr
Adjustment ₹12 Cr₹9.79 Cr₹3.89 Cr₹2.80 Cr₹-1.23 Cr
Changes In working Capital ₹-24 Cr₹-15 Cr₹-5.19 Cr₹39 Cr₹6.33 Cr
Cash Flow after changes in Working Capital ₹6.89 Cr₹6.92 Cr₹8.32 Cr₹47 Cr₹6.71 Cr
Cash Flow from Operating Activities ₹-0.15 Cr₹2.59 Cr₹5.78 Cr₹46 Cr₹4.46 Cr
Cash Flow from Investing Activities ₹-9.54 Cr₹7.92 Cr₹-15 Cr₹-38 Cr₹-10 Cr
Cash Flow from Financing Activities ₹8.81 Cr₹-0.72 Cr₹7.03 Cr₹1.61 Cr₹0.85 Cr
Net Cash Inflow / Outflow ₹-0.88 Cr₹9.78 Cr₹-2.44 Cr₹9.70 Cr₹-5.14 Cr
Opening Cash & Cash Equivalents ₹20 Cr₹10 Cr₹13 Cr₹2.80 Cr₹7.94 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹19 Cr₹20 Cr₹10 Cr₹13 Cr₹2.80 Cr

Compare Cashflow Statement of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹571.5 Cr 1.1% 1.2% -2.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,910.0 Cr 5.4% 3.2% 20.4% Stock Analytics
DIVIS LABORATORIES ₹160,035.0 Cr 1.9% 2% 59.4% Stock Analytics
CIPLA ₹125,540.0 Cr 1.7% 2% 13.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,894.0 Cr 2.8% 2.3% 22.8% Stock Analytics
DR REDDYS LABORATORIES ₹100,110.0 Cr 2.1% -0.9% -1.5% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

1.1%

1.2%

-2.3%

SENSEX

1%

4.3%

8.9%


You may also like the below Video Courses